摘要
目的建立检测正心降脂片中丹参酮ⅡA、葛根素和大黄素3种成分含量的方法。方法采用反向高效液相色谱(RPHPLC)法。取正心降脂片,除去包衣,研细,取约0.2 g,精密称定,置滤膜滤过,Lichrospher RP-C18色谱柱分离,检测波长为259 nm,流动相A为乙腈,流动相B为0.2%磷酸溶液,梯度洗脱,洗脱程序为0~6 min 12%A、6~15 min 12%~63%A、15~25 min 63%~92%A、25~27 min 91%A、27~30 min 91%~12%A、30~35 min 12%A,流速为1.0 mL/min,柱温为30℃,进样体积为10µL,二极管阵列检测器定量检测。结果葛根素、大黄素和丹参酮ⅡA分别在0.763~76.3µg/mL、0.768~76.8µg/mL和0.199~19.9µg/mL范围内,线性关系良好,平均加标回收率分别为98.5%,99.3%和99.6%,重复性相对标准偏差(RSD)分别为1.29%、2.05%和1.72%;稳定性RSD分别为2.03%、1.72%和1.33%。结论实验建立的方法具有简便、快速、准确等特点,适用于正心降脂片产品的质量控制,为进一步完善和提高该品种的质量标准提供技术参考。
Objective To establish method for determination 3 contents of tanshinoneⅡA,puerarin and emodin in Zhengxin Jiang⁃zhi tabets.Methods The coating of Zhengxin Jiangzhi Tabets samples was removed and grinded to powder.Weighing about 0.2 g pretreated samples precisely to 50 mL volumetric flask,ultrasonic treatment was performed with 95%methanol solution for 25 min.Vol‐ume the samples to 50 mL and shook it well.Samples was filtered by 0.45µm membrane filter and separated on Lichrospher RP-C18 column.Detection wavelength:259 nm.Mobile phase:acetonitrile(A)-0.2%phosphoric acid solution(B).Gradient elution procedure:0-6 min 12%A,6-15 min 12%-63%A,15-25 min 63%-92%A,25-27 min 91%A,27-30 min 91%-12%A,30-35 min 12%A.flow rate:1.0 mL/min,column temperature:30℃and injection volume was 10µL.Diode array detector was for quantitative detection.Re‑sults Puerarin,emodin and TanshinoneⅡA showed good linear relationships in following concentration range 1.526-76.3µg/mL,1.536-76.8µg/mL and 0.398-19.9µg/mL,respectively.Average recoveries were 98.5%,99.3%and 99.6%,respectively.Relative stan‐dard deviation(RSD)of repeatability(n=6)was 1.3%,1.7%and 1.1%,respectively.The stability of RSD was 2.03%,1.72%and 1.33%,respectively.Conclusion The method is simple,rapid and accurate,which is suitable for the quality control of Zhengxin Ji⁃angzhi Tabets.It also provides technical reference for further improving quality standard of this breed.
作者
曲春雁
崔国方
范广慈
张济涛
QU Chunyan;CUI Guofang;FAN Guangci;ZHANG Jitao(Department of Cardiovascular Medicine,Laoshan Maternal and Child Health Center,Qingdao,Shandong 266067,China;Department of Cardiology,Qingdao Haici Medical Group,Qingdao,Shandong 266011,China)
出处
《安徽医药》
CAS
2021年第11期2174-2177,共4页
Anhui Medical and Pharmaceutical Journal